Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging - Johnson, Keith A; Sperling, Reisa A; Gidicsin, Christopher M; Carmasin, Jeremy S; Maye, Jacqueline E; Coleman, Ralph E; Reiman, Eric M; Sabbagh, Marwan N; Sadowsky, Carl H; Fleisher, Adam S; Murali Doraiswamy, P; Carpenter, Alan P; et al. (Alzheimer's & dementia, 2013)
Keywords: Aged; Aged, 80 and over; Aging; Alzheimer Disease - diagnostic imaging; Alzheimer Disease - genetics; Alzheimer's disease; Amyloid; Amyloidogenic Proteins - metabolism; Amyvid; Aniline Compounds; Apolipoprotein E4 - genetics; Cognitive Dysfunction - diagnostic imaging; Cognitive Dysfunction - genetics; Female; Florbetapir; Fluorine Radioisotopes; Humans; Male; Mental Status Schedule; Mesh; Middle Aged; Neurology; PET; Positron-Emission Tomography; Stilbenes; Mesh; Amyloid; Florbetapir; Alzheimer's disease; PET; Amyvid